168 related articles for article (PubMed ID: 21242965)
21. Molecular mechanism of hTid-1, the human homolog of Drosophila tumor suppressor l(2)Tid, in the regulation of NF-kappaB activity and suppression of tumor growth.
Cheng H; Cenciarelli C; Nelkin G; Tsan R; Fan D; Cheng-Mayer C; Fidler IJ
Mol Cell Biol; 2005 Jan; 25(1):44-59. PubMed ID: 15601829
[TBL] [Abstract][Full Text] [Related]
22. Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells.
Navab R; Liu J; Seiden-Long I; Shih W; Li M; Bandarchi B; Chen Y; Lau D; Zu YF; Cescon D; Zhu CQ; Organ S; Ibrahimov E; Ohanessian D; Tsao MS
Neoplasia; 2009 Dec; 11(12):1292-300. PubMed ID: 20019837
[TBL] [Abstract][Full Text] [Related]
23. Identification of a hTid-1 mutation which sensitizes gliomas to apoptosis.
Trentin GA; He Y; Wu DC; Tang D; Rozakis-Adcock M
FEBS Lett; 2004 Dec; 578(3):323-30. PubMed ID: 15589840
[TBL] [Abstract][Full Text] [Related]
24. Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met.
van der Voort R; Taher TE; Wielenga VJ; Spaargaren M; Prevo R; Smit L; David G; Hartmann G; Gherardi E; Pals ST
J Biol Chem; 1999 Mar; 274(10):6499-506. PubMed ID: 10037743
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of c-met proto-oncogene associated with chromophilic renal cell carcinoma with papillary growth.
Inoue K; Karashima T; Chikazawa M; Iiyama T; Yoshikawa C; Furihata M; Ohtsuki Y; Shuin T
Virchows Arch; 1998 Dec; 433(6):511-5. PubMed ID: 9870683
[TBL] [Abstract][Full Text] [Related]
26. MAP kinase and beta-catenin signaling in HGF induced RPE migration.
Liou GI; Matragoon S; Samuel S; Behzadian MA; Tsai NT; Gu X; Roon P; Hunt DM; Hunt RC; Caldwell RB; Marcus DM
Mol Vis; 2002 Dec; 8():483-93. PubMed ID: 12500177
[TBL] [Abstract][Full Text] [Related]
27. HTLV-1 Tax-associated hTid-1, a human DnaJ protein, is a repressor of Ikappa B kinase beta subunit.
Cheng H; Cenciarelli C; Tao M; Parks WP; Cheng-Mayer C
J Biol Chem; 2002 Jun; 277(23):20605-10. PubMed ID: 11927590
[TBL] [Abstract][Full Text] [Related]
28. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.
Tiran Z; Oren A; Hermesh C; Rotman G; Levine Z; Amitai H; Handelsman T; Beiman M; Chen A; Landesman-Milo D; Dassa L; Peres Y; Koifman C; Glezer S; Vidal-Finkelstein R; Bahat K; Pergam T; Israel C; Horev J; Tsarfaty I; Ayalon-Soffer M
Clin Cancer Res; 2008 Jul; 14(14):4612-21. PubMed ID: 18628476
[TBL] [Abstract][Full Text] [Related]
29. Impact of MET inhibition on small-cell lung cancer cells showing aberrant activation of the hepatocyte growth factor/MET pathway.
Taniguchi H; Yamada T; Takeuchi S; Arai S; Fukuda K; Sakamoto S; Kawada M; Yamaguchi H; Mukae H; Yano S
Cancer Sci; 2017 Jul; 108(7):1378-1385. PubMed ID: 28474864
[TBL] [Abstract][Full Text] [Related]
30. Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels.
Mineo R; Costantino A; Frasca F; Sciacca L; Russo S; Vigneri R; Belfiore A
Endocrinology; 2004 Sep; 145(9):4355-65. PubMed ID: 15192042
[TBL] [Abstract][Full Text] [Related]
31. The human DnaJ protein, hTid-1, enhances binding of a multimer of the herpes simplex virus type 1 UL9 protein to oris, an origin of viral DNA replication.
Eom CY; Lehman IR
Proc Natl Acad Sci U S A; 2002 Feb; 99(4):1894-8. PubMed ID: 11854491
[TBL] [Abstract][Full Text] [Related]
32. The hepatocyte growth factor isoform NK2 activates motogenesis and survival but not proliferation due to lack of Akt activation.
Mungunsukh O; Lee YH; Bottaro DP; Day RM
Cell Signal; 2016 Aug; 28(8):1114-23. PubMed ID: 27224506
[TBL] [Abstract][Full Text] [Related]
33. с-Met receptor can be activated by extracellular alkaline medium.
Serova OV; Orsa AN; Chachina NA; Petrenko AG; Deyev IE
J Recept Signal Transduct Res; 2019 Feb; 39(1):67-72. PubMed ID: 31215287
[TBL] [Abstract][Full Text] [Related]
34. Cross talk between c-Met and epidermal growth factor receptor during retinal pigment epithelial wound healing.
Xu KP; Yu FS
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2242-8. PubMed ID: 17460286
[TBL] [Abstract][Full Text] [Related]
35. Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion.
Wang X; Le P; Liang C; Chan J; Kiewlich D; Miller T; Harris D; Sun L; Rice A; Vasile S; Blake RA; Howlett AR; Patel N; McMahon G; Lipson KE
Mol Cancer Ther; 2003 Nov; 2(11):1085-92. PubMed ID: 14617781
[TBL] [Abstract][Full Text] [Related]
36. PHA665752, a small-molecule inhibitor of c-Met, inhibits hepatocyte growth factor-stimulated migration and proliferation of c-Met-positive neuroblastoma cells.
Crosswell HE; Dasgupta A; Alvarado CS; Watt T; Christensen JG; De P; Durden DL; Findley HW
BMC Cancer; 2009 Nov; 9():411. PubMed ID: 19939254
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613
[TBL] [Abstract][Full Text] [Related]
38. Met overexpression confers HGF-dependent invasive phenotype to human thyroid carcinoma cells in vitro.
de Luca A; Arena N; Sena LM; Medico E
J Cell Physiol; 1999 Sep; 180(3):365-71. PubMed ID: 10430176
[TBL] [Abstract][Full Text] [Related]
39. Allosteric peptide activators of pro-hepatocyte growth factor stimulate Met signaling.
Landgraf KE; Santell L; Billeci KL; Quan C; Young JC; Maun HR; Kirchhofer D; Lazarus RA
J Biol Chem; 2010 Dec; 285(51):40362-72. PubMed ID: 20937841
[TBL] [Abstract][Full Text] [Related]
40. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.
Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER
Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]